• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-34 与心力衰竭患者肾功能障碍和冠状动脉疾病的存在和严重程度相关。

IL-34 is associated with the presence and severity of renal dysfunction and coronary artery disease in patients with heart failure.

机构信息

Department of Cardiology, Rui Jin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, P.R. China.

Institute of Cardiovascular Diseases, Shanghai Jiaotong University School of Medicine, Shanghai, P.R. China.

出版信息

Sci Rep. 2016 Dec 16;6:39324. doi: 10.1038/srep39324.

DOI:10.1038/srep39324
PMID:27982136
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5159784/
Abstract

Pro-inflammatory mediators are identified in patients with heart failure (HF), some of which may be used as biomarkers with diagnostic or prognostic value. As an additional ligand of Colony Stimulating Factor-1 Receptor (CSF-1R), interleukin-34 (IL-34) has been identified as a pro-inflammatory cytokine participating in chronic heart failure (CHF). However, the potential impact of IL-34 in CHF complications remains unknown. In order to determine the clinical significance of serum IL-34 in CHF patients, especially those with kidney dysfunction and coronary artery disease (CAD) comorbid conditions, serum IL-34 was measured in 510 consecutive patients with CHF in a cross-sectional study. The present study demonstrated that higher serum IL-34 levels were associated with poorer renal function and more severe anemia in patients with CHF. After adjusting for age, gender, conventional risk factors, and other significant covariates, IL-34 positively correlated with the presence and severity of renal dysfunction (as measured by eGFR and cystatin C) on multivariable linear and logistic regression analysis. IL-34 was also demonstrated to be an independent risk factor for CAD among HF patients. In conclusion, elevated serum IL-34 levels were demonstrated to be independently associated with renal insufficiency and CAD in patients with CHF, regardless of the systolic function.

摘要

在心力衰竭(HF)患者中鉴定出促炎介质,其中一些可能被用作具有诊断或预后价值的生物标志物。白细胞介素 34(IL-34)作为集落刺激因子 1 受体(CSF-1R)的附加配体,已被鉴定为参与慢性心力衰竭(CHF)的促炎细胞因子。然而,IL-34 在 CHF 并发症中的潜在影响尚不清楚。为了确定血清 IL-34 在 CHF 患者中的临床意义,特别是那些伴有肾功能不全和冠状动脉疾病(CAD)合并症的患者,本研究在一项横断面研究中测量了 510 例连续 CHF 患者的血清 IL-34。本研究表明,较高的血清 IL-34 水平与 CHF 患者的肾功能较差和更严重的贫血有关。在校正年龄、性别、常规危险因素和其他重要协变量后,IL-34 与肾功能障碍的存在和严重程度(通过 eGFR 和胱抑素 C 测量)呈正相关,多元线性和逻辑回归分析。IL-34 也是 HF 患者 CAD 的独立危险因素。总之,无论收缩功能如何,升高的血清 IL-34 水平均与 CHF 患者的肾功能不全和 CAD 独立相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6afe/5159784/ba23b8266022/srep39324-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6afe/5159784/ba23b8266022/srep39324-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6afe/5159784/ba23b8266022/srep39324-f1.jpg

相似文献

1
IL-34 is associated with the presence and severity of renal dysfunction and coronary artery disease in patients with heart failure.白细胞介素-34 与心力衰竭患者肾功能障碍和冠状动脉疾病的存在和严重程度相关。
Sci Rep. 2016 Dec 16;6:39324. doi: 10.1038/srep39324.
2
Prognostic Significance of Interleukin-34 (IL-34) in Patients With Chronic Heart Failure With or Without Renal Insufficiency.白细胞介素-34(IL-34)在合并或不合并肾功能不全的慢性心力衰竭患者中的预后意义。
J Am Heart Assoc. 2017 Apr 1;6(4):e004911. doi: 10.1161/JAHA.116.004911.
3
Increased Serum Interleukin-34 Levels Are Related to the Presence and Severity of Cardiac Dysfunction in Patients With Ischemic Cardiomyopathy.血清白细胞介素-34水平升高与缺血性心肌病患者心脏功能障碍的存在及严重程度相关。
Front Physiol. 2018 Jul 11;9:904. doi: 10.3389/fphys.2018.00904. eCollection 2018.
4
Relations between markers of renal function, coronary risk factors and the occurrence and severity of coronary artery disease.肾功能标志物、冠状动脉危险因素与冠状动脉疾病的发生及严重程度之间的关系。
Atherosclerosis. 2008 Apr;197(2):853-9. doi: 10.1016/j.atherosclerosis.2007.07.034. Epub 2007 Sep 10.
5
Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.肾功能、充血性心力衰竭与氨基末端脑钠肽前体测定:急诊科呼吸困难的脑钠肽前体研究(PRIDE)结果
J Am Coll Cardiol. 2006 Jan 3;47(1):91-7. doi: 10.1016/j.jacc.2005.08.051. Epub 2005 Dec 9.
6
NT-proBNP and CA 125 levels are associated with increased pro-inflammatory cytokines in coronary sinus serum of patients with chronic heart failure.NT-proBNP 和 CA125 水平与慢性心力衰竭患者冠状窦血清中促炎细胞因子的增加有关。
Cytokine. 2018 Nov;111:13-19. doi: 10.1016/j.cyto.2018.07.037. Epub 2018 Aug 8.
7
Prevalence of moderate and severe renal insufficiency in older persons with hypertension, diabetes mellitus, coronary artery disease, peripheral arterial disease, ischemic stroke, or congestive heart failure in an academic nursing home.学术型养老院中患有高血压、糖尿病、冠状动脉疾病、外周动脉疾病、缺血性中风或充血性心力衰竭的老年人中重度肾功能不全的患病率。
J Am Med Dir Assoc. 2008 May;9(4):257-9. doi: 10.1016/j.jamda.2008.01.002. Epub 2008 Apr 8.
8
Heart failure with anemia: novel findings on the roles of renal disease, interleukins, and specific left ventricular remodeling processes.贫血伴心力衰竭:关于肾脏疾病、白细胞介素及特定左心室重构过程作用的新发现
Circ Heart Fail. 2014 Sep;7(5):773-81. doi: 10.1161/CIRCHEARTFAILURE.114.001100. Epub 2014 Jul 15.
9
Altered serum levels of IL-33 in patients with advanced systolic chronic heart failure: correlation with oxidative stress.慢性心力衰竭患者血清中白细胞介素-33 水平的改变:与氧化应激的相关性。
J Transl Med. 2012 Jun 8;10:120. doi: 10.1186/1479-5876-10-120.
10
Prevalence of renal dysfunction and its influence on functional capacity in elderly patients with stable chronic heart failure.老年稳定型慢性心力衰竭患者肾功能不全的患病率及其对功能能力的影响。
Vojnosanit Pregl. 2012 Oct;69(10):840-5.

引用本文的文献

1
IL-34 aggravates myocardial ischemia-reperfusion injury by upregulating the HMGB1-IL-17A-IL-6 axis through the JAK signaling pathway.白细胞介素-34通过JAK信号通路上调高迁移率族蛋白B1-白细胞介素-17A-白细胞介素-6轴,加重心肌缺血-再灌注损伤。
PLoS One. 2025 Jan 30;20(1):e0315489. doi: 10.1371/journal.pone.0315489. eCollection 2025.
2
Cut-off value for interleukin-34 as an additional potential inflammatory biomarker for estimation of slow coronary flow risk.白细胞介素-34 作为评估慢血流风险的潜在炎症生物标志物的截断值。
BMC Cardiovasc Disord. 2024 Jan 2;24(1):2. doi: 10.1186/s12872-023-03677-y.
3
Prognostic value of interleukin-34 and interleukin-38 in patients with newly diagnosed atrial fibrillation.

本文引用的文献

1
Mendelian Randomisation study of the influence of eGFR on coronary heart disease.基于孟德尔随机化研究的肾小球滤过率对冠心病的影响。
Sci Rep. 2016 Jun 24;6:28514. doi: 10.1038/srep28514.
2
Renal biomarkers and outcomes in outpatients with heart failure: The Atlanta cardiomyopathy consortium.心力衰竭门诊患者的肾脏生物标志物与预后:亚特兰大心肌病联盟
Int J Cardiol. 2016 Sep 1;218:136-143. doi: 10.1016/j.ijcard.2016.05.041. Epub 2016 May 13.
3
The cut-off value for interleukin 34 as an additional potential inflammatory biomarker for the prediction of the risk of diabetic complications.
白细胞介素-34和白细胞介素-38在新诊断房颤患者中的预后价值
Front Cardiovasc Med. 2023 Jan 9;9:1072164. doi: 10.3389/fcvm.2022.1072164. eCollection 2022.
4
Bioinformatics and Experimental Analyses Reveal Immune-Related LncRNA-mRNA Pair - as a Biomarker and Therapeutic Target for Ischemic Cardiomyopathy.生物信息学和实验分析揭示免疫相关 lncRNA-mRNA 对 - 作为缺血性心肌病的生物标志物和治疗靶点。
Int J Mol Sci. 2022 Oct 9;23(19):11994. doi: 10.3390/ijms231911994.
5
Nonsteroidal Mineralocorticoid Receptor Antagonism by Finerenone-Translational Aspects and Clinical Perspectives across Multiple Organ Systems.非甾体类盐皮质激素受体拮抗剂费列罗酮:在多个器官系统中的转化意义和临床观点。
Int J Mol Sci. 2022 Aug 17;23(16):9243. doi: 10.3390/ijms23169243.
6
Combination of IL-34 and AFP improves the diagnostic value during the development of HBV related hepatocellular carcinoma.白细胞介素-34与甲胎蛋白联合检测可提高乙肝相关肝细胞癌发生过程中的诊断价值。
Clin Exp Med. 2023 Jun;23(2):397-409. doi: 10.1007/s10238-022-00810-7. Epub 2022 Mar 28.
7
IL-34 and coronary heart disease complicated with diabetes mellitus.白细胞介素-34 与冠心病合并糖尿病。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2021 Dec 28;46(12):1409-1414. doi: 10.11817/j.issn.1672-7347.2021.200797.
8
Clinical Implications of IL-32, IL-34 and IL-37 in Atherosclerosis: Speculative Role in Cardiovascular Manifestations of COVID-19.白细胞介素-32、白细胞介素-34和白细胞介素-37在动脉粥样硬化中的临床意义:在2019冠状病毒病心血管表现中的推测作用
Front Cardiovasc Med. 2021 Aug 6;8:630767. doi: 10.3389/fcvm.2021.630767. eCollection 2021.
9
Reno-protective effect of IL-34 inhibition on cisplatin-induced nephrotoxicity in mice.IL-34 抑制对顺铂诱导的小鼠肾毒性的肾保护作用。
PLoS One. 2021 Jan 11;16(1):e0245340. doi: 10.1371/journal.pone.0245340. eCollection 2021.
10
Emerging roles of IL-34 in health and disease.IL-34 在健康和疾病中的新作用。
J Exp Med. 2020 Mar 2;217(3). doi: 10.1084/jem.20190290.
白细胞介素34作为预测糖尿病并发症风险的另一种潜在炎症生物标志物的临界值。
Biomarkers. 2016;21(3):276-82. doi: 10.3109/1354750X.2016.1138321. Epub 2016 Feb 5.
4
Galectin-3 level and the severity of cardiac diastolic dysfunction using cellular and animal models and clinical indices.利用细胞和动物模型以及临床指标研究半乳糖凝集素-3水平与心脏舒张功能障碍的严重程度。
Sci Rep. 2015 Nov 19;5:17007. doi: 10.1038/srep17007.
5
IL-34 is a Treg-specific cytokine and mediates transplant tolerance.白细胞介素-34是一种调节性T细胞特异性细胞因子,可介导移植耐受。
J Clin Invest. 2015 Oct 1;125(10):3952-64. doi: 10.1172/JCI81227. Epub 2015 Sep 21.
6
IL-34 mediates acute kidney injury and worsens subsequent chronic kidney disease.白细胞介素-34介导急性肾损伤并加重随后的慢性肾脏病。
J Clin Invest. 2015 Aug 3;125(8):3198-214. doi: 10.1172/JCI81166. Epub 2015 Jun 29.
7
Interleukin 34: a new modulator of human and experimental inflammatory bowel disease.白细胞介素34:人类及实验性炎症性肠病的新型调节因子
Clin Sci (Lond). 2015 Aug;129(3):281-90. doi: 10.1042/CS20150176.
8
Innate immunity and the failing heart: the cytokine hypothesis revisited.先天性免疫与衰竭心脏:重新审视细胞因子假说。
Circ Res. 2015 Mar 27;116(7):1254-68. doi: 10.1161/CIRCRESAHA.116.302317.
9
Biomarkers and echocardiographic predictors of myocardial dysfunction in patients with hypertension.高血压患者心肌功能障碍的生物标志物和超声心动图预测指标
Sci Rep. 2015 Mar 9;5:8916. doi: 10.1038/srep08916.
10
Interleukin-34 promotes tumor progression and metastatic process in osteosarcoma through induction of angiogenesis and macrophage recruitment.白细胞介素-34通过诱导血管生成和巨噬细胞募集促进骨肉瘤的肿瘤进展和转移过程。
Int J Cancer. 2015 Jul 1;137(1):73-85. doi: 10.1002/ijc.29376. Epub 2014 Dec 13.